GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Total Debt per Share

Alligator Bioscience AB (LTS:0RK9) Total Debt per Share : kr4.85 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Total Debt per Share?

kr4.85 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Alligator Bioscience AB's Total Debt Per Share for the quarter that ended in Dec. 2024 was kr4.85.

Alligator Bioscience AB Total Debt per Share Historical Data

The historical data trend for Alligator Bioscience AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Total Debt per Share Chart

Alligator Bioscience AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.61 2.26 5.69 2.07 4.85

Alligator Bioscience AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.07 1.79 1.32 1.11 4.85

Alligator Bioscience AB Total Debt per Share Calculation

Alligator Bioscience AB's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(33.48+10.10)/8.99
=4.85

Alligator Bioscience AB's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(33.48+10.10)/8.99
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Total Debt per Share
Comparable Companies
OSTO:NICA OSTO:ACTI XSAT:BIOWKS OSTO:ELIC OSTO:KAN OSTO:BIOVIC B XSAT:ABERA OSTO:PILA OSTO:MVIR NGM:GTAB B VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ATORX:Sweden 7AL:Germany
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.alligatorbioscience.com
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB Headlines

No Headlines